UNSPSC 51261503: Indoramin

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51261503

Definition

This classification denotes a beta-adrenergic blocking agent with the molecular formula C22H25N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0Z802HMY7H, chemically known as benzamide, n-(1-(2-indol-3-ylethyl)-4-piperidyl)- but generally known as indoramin, which bears US NIH Compound Identifier 33625. European Medicines Agency schedules Indoramin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08184MIG.

Read the full definition

The term INDORAMIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25, No. 10 1971, List 11). World Health Organization schedules indoramin in its Anatomical Therapeutic Chemical (ATC) Classification. INDORAMIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule indoramin under HS 29333999 and SITC 51574. As of Q4 2014, INDORAMIN remains the US FDA Preferred Term for this commodity. Indoramin bears US NLM identifiers UMLS ID C0021252 and NCI Concept Code C65916.

SMILES: O=C(NC1CCN(CC1)CCC1C2C([NH]C1)CCCC2)C1CCCCC1.

About UNSPSC 51261503

UNSPSC 51261503 Indoramin is a Commodity code that covers pharmaceutical products, though recent state and local procurement activity under this code shows limited direct relevance to the code's specific drug classification. The solicitations tagged to this code reflect broader pharmaceutical and health-service procurement rather than indoramin specifically. State and local governments using this code are procuring naloxone (opioid reversal medication), safe drug deactivation systems, and exploring direct-to-manufacturer prescription programs as part of community health and pharmacy benefit initiatives. The issuing bodies include county health departments and state health and human services agencies, indicating procurement activity at both the county and state level.

Geographically, recent activity centers on Florida and Texas. Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023. The Texas Health and Human Services Commission issued Request for Information HHS0017013, posted April 3, 2026, to solicit vendor capabilities regarding direct-to-manufacturer prescription programs for its Therapeutic Pharmacy Initiative, seeking information from vendors on direct contracting experience with self-insured employers and government health plans. The Seminole County procurement requires electronic bid submission through the county's e-Procurement Portal, E-Verify compliance, and standard insurance coverage. Neither solicitation identifies explicit set-aside or disadvantaged-enterprise designations.

Quick answers

What is UNSPSC 51261503?

UNSPSC 51261503 is Indoramin, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51261503?

UNSPSC 51261503 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51261503

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code